United States Opioids Market Report & Forecast 2021-2027

United States Opioids Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Opioids Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Opioids Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Opioids Overall Market Size
2.1 United States Opioids Market Size: 2021 VS 2027
2.2 United States Opioids Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Opioids Sales: 2016-2027
3 Company Landscape
3.1 Top Opioids Players in United States Market
3.2 Top United States Opioids Companies Ranked by Revenue
3.3 United States Opioids Revenue by Companies
3.4 United States Opioids Sales by Companies
3.5 United States Opioids Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Opioids Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Opioids Product Type
3.8 Tier 1, Tier 2 and Tier 3 Opioids Players in United States Market
3.8.1 List of Tier 1 Opioids Companies in United States
3.8.2 List of Tier 2 and Tier 3 Opioids Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Opioids Market Size Markets, 2021 & 2027
4.1.2 Oxycodone
4.1.3 Hydromorphone
4.1.4 Codeine
4.1.5 Fentanyl
4.1.6 Other
4.2 By Type - United States Opioids Revenue & Forecasts
4.2.1 By Type - United States Opioids Revenue, 2016-2021
4.2.2 By Type - United States Opioids Revenue, 2022-2027
4.2.3 By Type - United States Opioids Revenue Market Share, 2016-2027
4.3 By Type - United States Opioids Sales & Forecasts
4.3.1 By Type - United States Opioids Sales, 2016-2021
4.3.2 By Type - United States Opioids Sales, 2022-2027
4.3.3 By Type - United States Opioids Sales Market Share, 2016-2027
4.4 By Type - United States Opioids Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Opioids Market Size, 2021 & 2027
5.1.2 Pain Relief
5.1.3 Anesthesia
5.1.4 Cough Suppression
5.1.5 Diarrhea Suppression
5.1.6 Deaddiction
5.1.7 Others
5.2 By Application - United States Opioids Revenue & Forecasts
5.2.1 By Application - United States Opioids Revenue, 2016-2021
5.2.2 By Application - United States Opioids Revenue, 2022-2027
5.2.3 By Application - United States Opioids Revenue Market Share, 2016-2027
5.3 By Application - United States Opioids Sales & Forecasts
5.3.1 By Application - United States Opioids Sales, 2016-2021
5.3.2 By Application - United States Opioids Sales, 2022-2027
5.3.3 By Application - United States Opioids Sales Market Share, 2016-2027
5.4 By Application - United States Opioids Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Teva
6.1.1 Teva Corporation Information
6.1.2 Teva Overview
6.1.3 Teva Opioids Sales and Revenue in United States Market (2016-2021)
6.1.4 Teva Opioids Product Description
6.1.5 Teva Recent Developments
6.2 Purdue Pharma
6.2.1 Purdue Pharma Corporation Information
6.2.2 Purdue Pharma Overview
6.2.3 Purdue Pharma Opioids Sales and Revenue in United States Market (2016-2021)
6.2.4 Purdue Pharma Opioids Product Description
6.2.5 Purdue Pharma Recent Developments
6.3 Mallinckrodt
6.3.1 Mallinckrodt Corporation Information
6.3.2 Mallinckrodt Overview
6.3.3 Mallinckrodt Opioids Sales and Revenue in United States Market (2016-2021)
6.3.4 Mallinckrodt Opioids Product Description
6.3.5 Mallinckrodt Recent Developments
6.4 Amneal Pharma
6.4.1 Amneal Pharma Corporation Information
6.4.2 Amneal Pharma Overview
6.4.3 Amneal Pharma Opioids Sales and Revenue in United States Market (2016-2021)
6.4.4 Amneal Pharma Opioids Product Description
6.4.5 Amneal Pharma Recent Developments
6.5 Collegium
6.5.1 Collegium Corporation Information
6.5.2 Collegium Overview
6.5.3 Collegium Opioids Sales and Revenue in United States Market (2016-2021)
6.5.4 Collegium Opioids Product Description
6.5.5 Collegium Recent Developments
6.6 J&J
6.6.1 J&J Corporation Information
6.6.2 J&J Overview
6.6.3 J&J Opioids Sales and Revenue in United States Market (2016-2021)
6.6.4 J&J Opioids Product Description
6.6.5 J&J Recent Developments
6.7 Endo
6.7.1 Endo Corporation Information
6.7.2 Endo Overview
6.7.3 Endo Opioids Sales and Revenue in United States Market (2016-2021)
6.7.4 Endo Opioids Product Description
6.7.5 Endo Recent Developments
6.8 Pfizer
6.8.1 Pfizer Corporation Information
6.8.2 Pfizer Overview
6.8.3 Pfizer Opioids Sales and Revenue in United States Market (2016-2021)
6.8.4 Pfizer Opioids Product Description
6.8.5 Pfizer Recent Developments
6.9 INSYS
6.9.1 INSYS Corporation Information
6.9.2 INSYS Overview
6.9.3 INSYS Opioids Sales and Revenue in United States Market (2016-2021)
6.9.4 INSYS Opioids Product Description
6.9.5 INSYS Recent Developments
6.10 Mylan
6.10.1 Mylan Corporation Information
6.10.2 Mylan Overview
6.10.3 Mylan Opioids Sales and Revenue in United States Market (2016-2021)
6.10.4 Mylan Opioids Product Description
6.10.5 Mylan Recent Developments
6.11 Hikma
6.11.1 Hikma Corporation Information
6.11.2 Hikma Overview
6.11.3 Hikma Opioids Sales and Revenue in United States Market (2016-2021)
6.11.4 Hikma Opioids Product Description
6.11.5 Hikma Recent Developments
6.12 Egalet
6.12.1 Egalet Corporation Information
6.12.2 Egalet Overview
6.12.3 Egalet Opioids Sales and Revenue in United States Market (2016-2021)
6.12.4 Egalet Opioids Product Description
6.12.5 Egalet Recent Developments
7 United States Opioids Production Capacity, Analysis
7.1 United States Opioids Production Capacity, 2016-2027
7.2 Opioids Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Opioids Supply Chain Analysis
9.1 Opioids Industry Value Chain
9.2 Opioids Upstream Market
9.3 Opioids Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Opioids Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Opioids in United States Market
Table 2. Top Opioids Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Opioids Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Opioids Revenue Share by Companies, 2016-2021
Table 5. United States Opioids Sales by Companies, (MT), 2016-2021
Table 6. United States Opioids Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Opioids Price (2016-2021) & (USD/Kg)
Table 8. Manufacturers Opioids Product Type
Table 9. List of Tier 1 Opioids Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Opioids Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Oxycodone
Table 12. Major Manufacturers of Hydromorphone
Table 13. By Type - United States Opioids Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Opioids Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Opioids Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Opioids Sales (MT), 2016-2021
Table 17. By Type - United States Opioids Sales (MT), 2022-2027
Table 18. By Application - United States Opioids Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Opioids Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Opioids Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Opioids Sales (MT), 2016-2021
Table 22. By Application - United States Opioids Sales (MT), 2022-2027
Table 23. Teva Corporation Information
Table 24. Teva Description and Major Businesses
Table 25. Teva Opioids Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 26. Teva Opioids Product
Table 27. Teva Recent Developments
Table 28. Purdue Pharma Corporation Information
Table 29. Purdue Pharma Description and Major Businesses
Table 30. Purdue Pharma Opioids Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 31. Purdue Pharma Opioids Product
Table 32. Purdue Pharma Recent Developments
Table 33. Mallinckrodt Corporation Information
Table 34. Mallinckrodt Description and Major Businesses
Table 35. Mallinckrodt Opioids Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 36. Mallinckrodt Opioids Product
Table 37. Mallinckrodt Recent Developments
Table 38. Amneal Pharma Corporation Information
Table 39. Amneal Pharma Description and Major Businesses
Table 40. Amneal Pharma Opioids Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 41. Amneal Pharma Opioids Product
Table 42. Amneal Pharma Recent Developments
Table 43. Collegium Corporation Information
Table 44. Collegium Description and Major Businesses
Table 45. Collegium Opioids Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 46. Collegium Opioids Product
Table 47. Collegium Recent Developments
Table 48. J&J Corporation Information
Table 49. J&J Description and Major Businesses
Table 50. J&J Opioids Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 51. J&J Opioids Product
Table 52. J&J Recent Developments
Table 53. Endo Corporation Information
Table 54. Endo Description and Major Businesses
Table 55. Endo Opioids Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 56. Endo Opioids Product
Table 57. Endo Recent Developments
Table 58. Pfizer Corporation Information
Table 59. Pfizer Description and Major Businesses
Table 60. Pfizer Opioids Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 61. Pfizer Opioids Product
Table 62. Pfizer Recent Developments
Table 63. INSYS Corporation Information
Table 64. INSYS Description and Major Businesses
Table 65. INSYS Opioids Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 66. INSYS Opioids Product
Table 67. INSYS Recent Developments
Table 68. Mylan Corporation Information
Table 69. Mylan Description and Major Businesses
Table 70. Mylan Opioids Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 71. Mylan Opioids Product
Table 72. Mylan Recent Developments
Table 73. Hikma Corporation Information
Table 74. Hikma Description and Major Businesses
Table 75. Hikma Opioids Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 76. Hikma Opioids Product
Table 77. Hikma Recent Developments
Table 78. Egalet Corporation Information
Table 79. Egalet Description and Major Businesses
Table 80. Egalet Opioids Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 81. Egalet Opioids Product
Table 82. Egalet Recent Developments
Table 83. Opioids Production Capacity (MT) of Key Manufacturers in United States Market, 2019-2021 (MT)
Table 84. United States Opioids Capacity Market Share of Key Manufacturers, 2019-2021
Table 85. Opioids Market Opportunities & Trends in United States Market
Table 86. Opioids Market Drivers in United States Market
Table 87. Opioids Market Restraints in United States Market
Table 88. Opioids Raw Materials
Table 89. Opioids Raw Materials Suppliers in United States Market
Table 90. Typical Opioids Downstream
Table 91. Opioids Downstream Clients in United States Market
Table 92. Opioids Distributors and Sales Agents in United States Market
List of Figures
Figure 1. Opioids Product Picture
Figure 2. Opioids Segment by Type
Figure 3. Opioids Segment by Application
Figure 4. United States Opioids Market Overview: 2020
Figure 5. United States Opioids Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Opioids Revenue, 2016-2027 (US$, Mn)
Figure 7. Opioids Sales in United States Market: 2016-2027 (MT)
Figure 8. The Top 3 and 5 Players Market Share by Opioids Revenue in 2020
Figure 9. Oxycodone Product Picture
Figure 10. Hydromorphone Product Picture
Figure 11. Codeine Product Picture
Figure 12. Fentanyl Product Picture
Figure 13. Other Product Picture
Figure 14. By Type - United States Opioids Sales Market Share, 2016-2027
Figure 15. By Type - United States Opioids Revenue Market Share, 2016-2027
Figure 16. By Type - United States Opioids Price (USD/Kg), 2016-2027
Figure 17. Pain Relief
Figure 18. Anesthesia
Figure 19. Cough Suppression
Figure 20. Diarrhea Suppression
Figure 21. Deaddiction
Figure 22. By Application - United States Opioids Sales Market Share, 2016-2027
Figure 23. By Application - United States Opioids Revenue Market Share, 2016-2027
Figure 24. By Application - United States Opioids Price (USD/Kg), 2016-2027
Figure 25. Teva Opioids Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Purdue Pharma Opioids Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Mallinckrodt Opioids Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Amneal Pharma Opioids Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Collegium Opioids Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. J&J Opioids Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. Endo Opioids Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 32. Pfizer Opioids Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 33. INSYS Opioids Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 34. Mylan Opioids Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 35. Hikma Opioids Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 36. Egalet Opioids Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 37. United States Opioids Production Capacity (MT), 2016-2027
Figure 38. Opioids Industry Value Chain
Figure 39. Marketing Channels

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Pain Management Drugs Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 93

Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about The drugs for pain management. The global Pain Management Drugs market was valued at US$ 35360 million in 2023 and is anticipated to reach US$ 44550 million by 2030, witnessing a CAGR of 3.3% during The forecast period 2024-2030. The leading manufacturers in The industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13......

Global Pain Management Drugs Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131

According to our LPI (LP Information) latest study, the global Pain Management Drugs market size was valued at US$ 34590 million in 2023. With growing demand in downstream market, the Pain Management Drugs is forecast to a readjusted size of US$ 43780 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Pain Management Drugs market. Pain Management Drugs are expected to show stable growth in the future market. However......

Global Opioids Drug Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115

According to our LPI (LP Information) latest study, the global Opioids Drug market size was valued at US$ 9831.4 million in 2023. With growing demand in downstream market, the Opioids Drug is forecast to a readjusted size of US$ 8616.1 million by 2030 with a CAGR of -1.9% during review period. The research report highlights the growth potential of the global Opioids Drug market. Opioids Drug are expected to show stable growth in the future market. However, product differentiation, reduci......

Global Methadone Hydrochloride Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90

According to our LPI (LP Information) latest study, the global Methadone Hydrochloride market size was valued at US$ 63 million in 2023. With growing demand in downstream market, the Methadone Hydrochloride is forecast to a readjusted size of US$ 88 million by 2030 with a CAGR of 5.0% during review period. The research report highlights the growth potential of the global Methadone Hydrochloride market. Methadone Hydrochloride are expected to show stable growth in the future market. Howev......

Global Opioids Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 112

Market Overview of Global Opioids Drugs market: According to our latest research, the global Opioids Drugs market looks promising in the next 5 years. As of 2022, the global Opioids Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescript......

Global Opioids Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 111

According to our (Global Info Research) latest study, the global Opioids Drug market size was valued at USD 10340 million in 2023 and is forecast to a readjusted size of USD 9156.6 million by 2030 with a CAGR of -1.7% during review period. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. The......

Global Methadone Hydrochloride Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 87

According to our (Global Info Research) latest study, the global Methadone Hydrochloride market size was valued at USD 66 million in 2023 and is forecast to a readjusted size of USD 90 million by 2030 with a CAGR of 4.6% during review period. Methadone Hydrochloride is a white, crystalline material that is water-soluble. It is an opioid used to treat pain or as maintenance therapy to help with detoxification in people with opioid dependence. Market Competition is not intense, as t......

Global Pain Management Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 131

According to our (Global Info Research) latest study, the global Pain Management Drugs market size was valued at USD 36380 million in 2023 and is forecast to a readjusted size of USD 45230 million by 2030 with a CAGR of 3.2% during review period. Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about the drugs for pain management. The leading manufacturers in the industry are GSK, Pfizer and Grune......

Global Fibromyalgia Drugs Market Research Report 2023, Forecast to 2028

Published: 28-Dec-2023        Price: US 2680 Onwards        Pages: 167

The FDA has approved three drugs to treat fibromyalgia: the antidepressants duloxetine (Cymbalta) and milnacipran (Savella), plus the anti-seizure medicine pregabalin (Lyrica). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging oppo......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs